L-Carnitine to Reduce Chemoradiotherapy-Induced Toxicity in Head and Neck Cancer: A Randomized Study.
- 2025-06-19
- RCT
- Head & neck 47(11)
- Kumari Puja
- Kamna Singh
- Indira Yadav
- Ashok Kumar Arya
- PubMed: 40536003
- DOI: 10.1002/hed.28221
- High evidence
- Clinical
Mean post-treatment BFI in the test arm versus control arm was 37.22 and 52.24 (p-value 0.042)
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 500 mg thrice daily